MAPT and Alzheimer disease: P-tau/Aβ42 ratio possesses higher sensitivity and specificity for differentiating AD from healthy controls and from other dementias, as compared to T-tau/Aβ42 ratio (Maddalena et al., 2003; Holtzman, 2011).